Large B-Cell Lymphoma Lawsuit Filed Over Roundup Exposure Risks

A Nebraska man indicates that he developed large B-cell lymphoma from Roundup exposure, alleging that Monsanto failed to warn consumers that their popular weedkiller may increase the risk of various forms of non-Hodgkins lymphoma in recently filed product liability lawsuit.

Daniel Kowal filed a complaint (PDF) in the Superior Court of the State of Delaware on November 23, indicating that he used Roundup for years, unaware that it carried a potential cancer risk, due to Monsanto’s marketing of the weed killer as “safer than table salt.”

The lawsuit claims that exposure to two ingredients in Roundup, glyphosate and the surfactant polyethoxylated tallow amine (POEA), caused Kowal’s diagnosis of Large B-cell lymphoma, which may have been avoided if the manufacturer had provided warnings and safety instructions that would have limited exposure to the herbicide.

ROUNDUP LAWSUITS

Were you or a loved one exposed to RoundUp?

Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin's Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated.

Learn More See If You Qualify For Compensation

Kowal indicates that he and other agricultural workers were unaware of the link between Roundup and cancer until last year, when the World Health Organization’s International Agency for Research on Cancer (IARC) determined that glyphosate contained in Roundup is likely a cancer-causing agent. In particular, the IARC report linked the side effects of Roundup to an increased risk of non-Hodgkins lymphoma.

“Glyphosate, and Defendant’s Roundup products in particular, have long been associated with serious side effects and many regulatory agencies around the globe have banned or are currently banning the use of glyphosate herbicide products,” the lawsuit notes. “Defendant’s statements proclaiming the safety of Roundup and disregarding its dangers misled Plaintiff.”

The case joins a growing number of Roundup lawsuits filed throughout the United States, typically involving individuals diagnosed with large B-cell lymphoma or another form of non-Hodgkin’s lymphoma following regular and consistent exposure to Roundup as a farm or agricultural worker. The plaintiffs allege that the manufacturer recklessly promoted Roundup and pushed greater and greater use of the chemical, without disclosing the potential health risks.

A recent U.S. Geological Survey on glyphosate usage nationwide found that an estimated 2.6 billion pounds of the herbicide has been sprayed on America’s agricultural land over the two decades since the mid-1990s, when Monsanto introduced “Roundup Ready” crops that are designed to survive being sprayed with glyphosate, killing the weeds but not the crops.

The lawsuits over Roundup allege that plaintiffs may have avoided a diagnosis of non-Hodgkin’s lymphoma or other cancers if they had been warned about the Roundup risks for farmers, landscapers and others in the agricultural industry, as safety precautions could have been taken or other products could have been used to control the growth of weeds.

While Kowal’s lawsuit was filed in state court, most Roundup cases have been filed at the federal level and are being transferred to the recently established MDL, or multidistrict litigation. Those complaints filed in U.S. District Courts nationwide have been centralized before U.S. District Judge Vince Chhabria in the Northern District of California, for coordinated discovery and pretrial proceedings.

Following coordinated proceedings before Judge Chhabria, if Roundup cancer settlements or another resolution for the cases are not reached, those complaints may be remanded back to the federal courts where they were originally filed for individual trial dates.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits
Ozempic MDL Court To Evaluate Need for Gastroparesis Diagnostic Testing in GLP-1 Lawsuits (Posted yesterday)

A federal judge has agreed to divide lawsuits over gastroparesis injuries linked to drugs like Ozempic and Mounjaro into multiple phases, examining how the condition is diagnosed and whether plaintiffs' claims are preempted by federal laws.

Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn
Adult Woman Files Similac Lawsuit Over NEC Injuries Experienced as a Newborn (Posted 2 days ago)

Lawsuit alleges that Abbott Laboratories failed to provide families and the medical community with adequate warnings about the risks associated with it’s cow’s milk-based Similac formula, which a now adult woman indicates has left her with life-long NEC injuries.

Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects
Amended Lawsuit Over BioZorb Implant Side Effects Outlines Problems Caused By Tissue Marker Design Defects (Posted 3 days ago)

Six breast cancer patients have asked a federal judge for permission to amend a complaint filed in March 2024, which describes problems linked to the device and painful side effects experienced when the tissue marker migrated out of position or shattered inside their bodies.